
BIOX Stock Forecast & Price Target
BIOX Analyst Ratings
Bulls say
Bioceres Crop Solutions demonstrates a positive outlook through its resilient Crop Protection portfolio, which, despite losing some market share in Argentina, is well-positioned to capitalize on a potential recovery in local farmer demand. The company is also benefiting from robust international opportunities, particularly with its HB4 wheat technology, which is expected to generate significant revenue in key markets such as the US, Brazil, and Australia. Additionally, sustained growth in bio-protection products and adjuvant sales outside of Argentina has helped offset weaker domestic performance, further supporting the company's overall financial health.
Bears say
Bioceres Crop Solutions Corp has experienced a significant decline in its top line, primarily driven by weaker demand for its Crop Protection and Crop Nutrition solutions in Argentina, alongside decreased revenue from the HB4-related sales following a strategic shift to a licensing-based business model. The company’s Crop Nutrition segment reported a notable year-over-year decline of approximately 34%, totaling around $25 million, attributed to softer market demand and pricing pressures exacerbated by reduced corn acreage. Additionally, revenues from Seed & Integrated products plummeted nearly 75% year-over-year to approximately $8 million, reflecting the company's transition away from seed production and sales as part of its new business strategy.
This aggregate rating is based on analysts' research of Bioceres Crop Solutions Corp and is not a guaranteed prediction by Public.com or investment advice.
BIOX Analyst Forecast & Price Prediction
Start investing in BIOX
Order type
Buy in
Order amount
Est. shares
0 shares